Product Information

PREGABALIN 300 MG CAPSULE is a generic product labeled by Torrent Pharmaceuticals Limited, priced at $0.0695 per EA under NDC 13668036505. Its NADAC has been published 49 times since Dec 17, 2025.

FDA first approved this application on Feb 21, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PREGABALIN 300 MG CAPSULE

Pregabalin
$0.0695per EA
DEA Schedule CV

Strength

300 mg/1

NDC

13668036505

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

PREGABALIN

Approval Type

Generic (ANDA)

FDA Application

ANDA206942

FDA Approved

2/21/2025

TE Code

AB

On Market Since

5/19/2025

Price Statistics

The NADAC for PREGABALIN 300 MG CAPSULE has been published 49 times since Dec 17, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.0695 per EA
All-time high$0.0695 (Nov 18, 2026)
All-time low$0.0644 (Aug 19, 2026)
52-week high$0.0695
52-week low$0.0644
Median price$0.0660
Average price$0.0664
Largest weekly change+3.7% (Oct 21, 2026)
Weeks tracked49
Tracking sinceDec 17, 2025

Price History

1W

+0.8%

1M

+4.5%

3M

+8.0%

6M

+6.6%

1Y

N/A

3Y

N/A

5Y

N/A

All

+0.4%

Generic Alternatives

The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of PREGABALIN 300 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for PREGABALIN 300 MG CAPSULE, manufactured by Torrent Pharmaceuticals Limited, is $0.0695 per EA (NDC 13668036505), effective Nov 18, 2026.

How has the price of PREGABALIN 300 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for PREGABALIN 300 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 49 weekly CMS publications since Dec 17, 2025.

What are the highest and lowest recorded NADAC prices for PREGABALIN 300 MG CAPSULE?

Since Dec 17, 2025, the NADAC for PREGABALIN 300 MG CAPSULE has ranged from a low of $0.0644 (Aug 19, 2026) to a high of $0.0695 (Nov 18, 2026), with a median of $0.0660 per EA.

Are there cheaper alternatives to PREGABALIN 300 MG CAPSULE?

Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PREGABALIN 300 MG CAPSULE, is $0.0669 per EA — about 4% below PREGABALIN 300 MG CAPSULE.

Who manufactures PREGABALIN 300 MG CAPSULE?

PREGABALIN 300 MG CAPSULE (NDC 13668036505) is labeled by Torrent Pharmaceuticals Limited, and CMS classifies it as a generic product.